VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
Source: pr-inside.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Peden. Real-time updates on events, politics, business and more.